Overview

A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)

Status:
Withdrawn
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study will compare vernakalant therapy to amiodarone therapy in the acute management of recent onset atrial fibrillation.
Phase:
Phase 4
Details
Lead Sponsor:
Cardiome Pharma
Correvio International Sarl
Treatments:
Amiodarone